Home » Aveo Announces Successful Completion of Discovery Agreement for Novel Cancer Drugs
Aveo Announces Successful Completion of Discovery Agreement for Novel Cancer Drugs
Aveo Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, announced it has successfully completed its multi-year collaborative agreement with Merck & Co., Inc., which utilized Aveo’s proprietary cancer models to identify and validate essential tumor maintenance genes which are attractive targets for the development of small molecule oncology agents.
Aveo
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May